<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Polymorphisms in Turkish population &#187; study</title>
	<atom:link href="http://polymorphisms.info/tag/study/feed" rel="self" type="application/rss+xml" />
	<link>http://polymorphisms.info</link>
	<description></description>
	<lastBuildDate>Thu, 19 May 2011 20:57:51 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Analysis of transforming growth factor beta 1 (TGF-beta1) gene polymorphisms in Turkish patients with scleroderma.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/analysis-of-transforming-growth-factor-beta-1-tgf-beta1-gene-polymorphisms-in-turkish-patients-with-scleroderma.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/analysis-of-transforming-growth-factor-beta-1-tgf-beta1-gene-polymorphisms-in-turkish-patients-with-scleroderma.html#comments</comments>
		<pubDate>Fri, 23 Jul 2010 14:05:52 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[Abstract]]></category>
		<category><![CDATA[ACE]]></category>
		<category><![CDATA[Biochem]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[control group]]></category>
		<category><![CDATA[gene polymorphism]]></category>
		<category><![CDATA[Genetic]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[genotype frequencies]]></category>
		<category><![CDATA[increase]]></category>
		<category><![CDATA[Istanbul]]></category>
		<category><![CDATA[patient]]></category>
		<category><![CDATA[PCR]]></category>
		<category><![CDATA[polymorphic]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[Turk]]></category>
		<category><![CDATA[Turkey]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=323</guid>
		<description><![CDATA[Cell Biochem Funct. 2010 Jun;28(4):274-7.
Büyük U, Ates O, Dalyan L, Müsellim B, Ongen G, Topal-Sarikaya A.
Department of Molecular Biology and Genetics, Istanbul University, Turkey. atopal@istanbul.edu.tr

Abstract
Systemic sclerosis (SSc) is an autoimmune disease characterized by inflammation and fibrosis of the skin and visceral organs. Fibrosis associated with SSc is characterized by an increased synthesis of a wide [...]]]></description>
			<content:encoded><![CDATA[<p>Cell Biochem Funct. 2010 Jun;28(4):274-7.</p>
<p>Büyük U, Ates O, Dalyan L, Müsellim B, Ongen G, Topal-Sarikaya A.</p>
<p>Department of Molecular Biology and Genetics, Istanbul University, Turkey. atopal@istanbul.edu.tr</p>
<div>
<h3>Abstract</h3>
<p>Systemic sclerosis (SSc) is an autoimmune disease characterized by inflammation and fibrosis of the skin and visceral organs. Fibrosis associated with SSc is characterized by an increased synthesis of a wide range of extracellular matrix (ECM). TGF-beta is a pluripotent cytokine in a wide range of cell types. In particular it has been found to be a potent inducer of ECM protein synthesis and fibroblast migration. The TGF-beta1 gene is highly polymorphic and two signal sequence polymorphisms at codon 10 and codon 25 are linked to disease outcomes. In this study, we analysed two polymorphic sites of the TGF-beta1 gene, codon 10 and codon 25, in 43 Turkish SSc female patients with interstitial lung involvement and in 75 healty individuals by ARMS-PCR. In our study no significant difference was found in codon 10, codon 25 genotype frequencies between patient with SSc and the control group (p = 0.676, 0.375, respectively). Our findings suggest that codon 10 and 25 polymorphism cannot be related with SSc for Turkish population. 2010 John Wiley &amp; Sons, Ltd.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/analysis-of-transforming-growth-factor-beta-1-tgf-beta1-gene-polymorphisms-in-turkish-patients-with-scleroderma.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vascular endothelial growth factor +405 C/G polymorphism is highly associated with an increased risk of endometriosis in Turkish women.</title>
		<link>http://polymorphisms.info/cancer-kanser/kategorisiz/vascular-endothelial-growth-factor-405-cg-polymorphism-is-highly-associated-with-an-increased-risk-of-endometriosis-in-turkish-women.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/kategorisiz/vascular-endothelial-growth-factor-405-cg-polymorphism-is-highly-associated-with-an-increased-risk-of-endometriosis-in-turkish-women.html#comments</comments>
		<pubDate>Fri, 05 Feb 2010 20:43:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Kategorilenmemiş]]></category>
		<category><![CDATA[allele]]></category>
		<category><![CDATA[altinkaya]]></category>
		<category><![CDATA[altinkayaozlem]]></category>
		<category><![CDATA[Arch]]></category>
		<category><![CDATA[chi square]]></category>
		<category><![CDATA[CONCLUSIONS]]></category>
		<category><![CDATA[Demographic]]></category>
		<category><![CDATA[difference]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[endometrial]]></category>
		<category><![CDATA[Endometriosis]]></category>
		<category><![CDATA[evidence]]></category>
		<category><![CDATA[extraction]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Gungor]]></category>
		<category><![CDATA[hospital]]></category>
		<category><![CDATA[Nominal]]></category>
		<category><![CDATA[OBJECTIVE]]></category>
		<category><![CDATA[Pearson Chi-square]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[restriction]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[Tahir Burak]]></category>
		<category><![CDATA[uterine]]></category>
		<category><![CDATA[vascular]]></category>
		<category><![CDATA[Women]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=299</guid>
		<description><![CDATA[Arch Gynecol Obstet. 2009 Dec 30. 
Altinkaya SO, Ugur M, Ceylaner G, Ozat M, Gungor T, Ceylaner S.
Department of Infertility, Zekai Tahir Burak Women&#8217;s Health Care Education and Research Hospital, Ankara, Turkey, altinkayaozlem@yahoo.com.

OBJECTIVE: Endometriosis is a chronic gynecological disease characterized by the growth of hormonally responsive, endometrial tissue outside the uterine cavity. The present study aims [...]]]></description>
			<content:encoded><![CDATA[<p>Arch Gynecol Obstet. 2009 Dec 30. </p>
<p>Altinkaya SO, Ugur M, Ceylaner G, Ozat M, Gungor T, Ceylaner S.</p>
<p>Department of Infertility, Zekai Tahir Burak Women&#8217;s Health Care Education and Research Hospital, Ankara, Turkey, altinkayaozlem@yahoo.com.</p>
<div>
<p>OBJECTIVE: Endometriosis is a chronic gynecological disease characterized by the growth of hormonally responsive, endometrial tissue outside the uterine cavity. The present study aims to analyze two vascular endothelial growth factor (VEGF) polymorphisms (-460 C/T and +405 C/G) in Turkish women with and without endometriosis. STUDY DESIGN: A case-control study was undertaken at the Infertility Department of Zekai Tahir Burak Women&#8217;s Health Care Education and Research Hospital. The single nucleotide polymorphisms, -460 C/T and +405 C/G, in the 5&#8242;-untranslated region of the VEGF gene were tested in 98 affected women and 94 women with no laparoscopic evidence of disease. Endometriosis was also confirmed histologically. Following genomic extraction of genomic DNA, genotyping of the -460 C/T and +405 C/G polymorphisms of the VEGF gene were performed by polymerase chain reaction and restriction fragment length polymorphism assay. Nominal data were evaluated by Pearson Chi-square or Fisher&#8217;s Exact test, where applicable. Odds ratios and 95% confidence intervals were also calculated. A P value less than 0.05 was considered statistically significant. RESULTS: Demographic data were similar among groups. The genotype and allele frequencies of the -460 C/T polymorphism did not differ significantly between cases and controls. In contrast, the genotype (P &lt; 0.001) and allele frequencies (P &lt; 0.001) of +405 C/G polymorphism showed a significant difference between cases and controls. Regardless of the early or advanced stage, women with endometriosis showed a higher incidence of the +405 GC genotype and +405G allele when compared with the controls. CONCLUSIONS: These data suggest that VEGF +405 GC genotype and +405G allele may be associated with the risk of developing early and advanced stage endometriosis in the Turkish population.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/kategorisiz/vascular-endothelial-growth-factor-405-cg-polymorphism-is-highly-associated-with-an-increased-risk-of-endometriosis-in-turkish-women.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey</title>
		<link>http://polymorphisms.info/gene-polymorphisms/interleukin-10-gene-promoter-polymorphism-in-patients-with-schizophrenia-in-a-region-of-east-turkey.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/interleukin-10-gene-promoter-polymorphism-in-patients-with-schizophrenia-in-a-region-of-east-turkey.html#comments</comments>
		<pubDate>Wed, 20 Jan 2010 23:47:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[Interleukin]]></category>
		<category><![CDATA[schizophrenia]]></category>
		<category><![CDATA[Activation]]></category>
		<category><![CDATA[allele]]></category>
		<category><![CDATA[Biol]]></category>
		<category><![CDATA[Biological]]></category>
		<category><![CDATA[Distribution]]></category>
		<category><![CDATA[fragment length polymorphism]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[gene promoter]]></category>
		<category><![CDATA[Genetic]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Genotypes]]></category>
		<category><![CDATA[Genotyping]]></category>
		<category><![CDATA[homozygote]]></category>
		<category><![CDATA[Human]]></category>
		<category><![CDATA[Humans]]></category>
		<category><![CDATA[Ozbey]]></category>
		<category><![CDATA[PCR]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymorphic]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[promoter region]]></category>
		<category><![CDATA[Psychiatric]]></category>
		<category><![CDATA[restriction]]></category>
		<category><![CDATA[restriction fragment]]></category>
		<category><![CDATA[restriction fragment length]]></category>
		<category><![CDATA[schizophrenic patients]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[turkish population]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=286</guid>
		<description><![CDATA[Author(s): Ozbey U (Ozbey, Ulku)2, Tug E (Tug, Esra)1, Namli M (Namli, Mustafa)3
Source: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY Volume: 10 Issue: 5 Pages: 461-468 Published: 2009
Abstract: Schizophrenia is one of the most severe psychiatric disorders, with a worldwide incidence of 1%. Immunological abnormalities have been found to be associated with schizophrenia for decades. Cytokines are [...]]]></description>
			<content:encoded><![CDATA[<p>Author(s): Ozbey U (Ozbey, Ulku)2, Tug E (Tug, Esra)1, Namli M (Namli, Mustafa)3<br />
Source: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY Volume: 10 Issue: 5 Pages: 461-468 Published: 2009</p>
<p><strong>Abstract:</strong> Schizophrenia is one of the most severe psychiatric disorders, with a worldwide incidence of 1%. Immunological abnormalities have been found to be associated with schizophrenia for decades. Cytokines are key proteins involved in the immune system activation. Interleukin-10 (IL-10), an important immunoregulatory cytokine, is located on chromosome 1q31 32, a region previously reported to be linked to schizophrenia in genetic studies. In the present study it was aimed to examine the IL-10 gene promoter region&#8217;s polymorphic variants in patients with schizophrenia in a population of the Elazig Region of East Anatolia, Turkey. Polymorphisms at position -1082, -819 and -592 in the IL-10 promoter region were determined in 171 Turkish patients who were diagnosed with schizophrenia, based on the DSM-IV, and 168 healthy controls, by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). We analyzed allele, genotype, and haplotype distributions using a case-control association study. Genotyping was performed by RFLP. Statistically significant differences were observed in both allelic and genotypic frequencies of the -592A/C polymorphism (Allele, P = 0.034, OR = 1.26, 95% CI 1.02 &#8211; 1.56; Genotype, P = 0.048), while the other two polymorphisms in distribution of the alleles and genotypes in patients with schizophrenia were not significantly different from those of controls (P &gt; 0.05). Our results show a significant increase of GTA homozygotes (the high IL-10-producing haplotype) in schizophrenic patients compared to control subjects (P = 0.0001). These data suggest that the IL-10 gene promoter polymorphism may be one of the susceptibility factors to develop schizophrenia in the Turkish population, and apparently in all humans.<br />
Document Type: Article<br />
Language: English<br />
Author Keywords: Biological psychiatry; cytokines; genetics; polymorphism; schizophrenia<br />
KeyWords Plus: ASSOCIATION; HAPLOTYPES; POPULATION; LINKAGE<br />
Reprint Address: Tug, E (reprint author), Abant Izzet Baysal Univ, Izzet Baysal Med Sch, Dept Med Genet, TR-14280 Bolu, Turkey<br />
Addresses:<br />
1. Abant Izzet Baysal Univ, Izzet Baysal Med Sch, Dept Med Genet, TR-14280 Bolu, Turkey<br />
2. Firat Univ, Fac Med, Dept Med Biol &amp; Genet, TR-23169 Elazig, Turkey<br />
3. Hosp Psychiat, Elazig, Turkey<br />
E-mail Addresses: esratug@hotmail.com</p>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/interleukin-10-gene-promoter-polymorphism-in-patients-with-schizophrenia-in-a-region-of-east-turkey.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome.</title>
		<link>http://polymorphisms.info/capn10/genetic-polymorphisms-of-fshr-cyp17-cyp1a1-capn10-insr-serpine1-genes-in-adolescent-girls-with-polycystic-ovary-syndrome.html</link>
		<comments>http://polymorphisms.info/capn10/genetic-polymorphisms-of-fshr-cyp17-cyp1a1-capn10-insr-serpine1-genes-in-adolescent-girls-with-polycystic-ovary-syndrome.html#comments</comments>
		<pubDate>Wed, 29 Apr 2009 19:39:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[CAPN10]]></category>
		<category><![CDATA[SERPINE1]]></category>
		<category><![CDATA[adolescence]]></category>
		<category><![CDATA[Ankara]]></category>
		<category><![CDATA[Besevler]]></category>
		<category><![CDATA[Bideci]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[CAPN]]></category>
		<category><![CDATA[Cinaz]]></category>
		<category><![CDATA[CYP]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[frequency]]></category>
		<category><![CDATA[Gazi]]></category>
		<category><![CDATA[genet]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[INSR]]></category>
		<category><![CDATA[J Assist]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Menevse]]></category>
		<category><![CDATA[nucleotide]]></category>
		<category><![CDATA[Onen]]></category>
		<category><![CDATA[PCOS]]></category>
		<category><![CDATA[PCR-RFLP]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[SERPINE]]></category>
		<category><![CDATA[SNPs]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[syndrome]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[Unsal]]></category>
		<category><![CDATA[Yilmaz]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=230</guid>
		<description><![CDATA[J Assist Reprod Genet. 2009 Apr 22.

Unsal T, Konac E, Yesilkaya E, Yilmaz A, Bideci A, Ilke Onen H, Cinaz P, Menevse A.
Department of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Besevler, 6500, Ankara, Turkey.
BACKGROUND: Polycystic ovary syndrome (PCOS), whose genetic basis is not completely well understood, is the most common endocrine disorder [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Journal of assisted reproduction and genetics."><a href="javascript:AL_get(this, 'jour', 'J Assist Reprod Genet.');">J Assist Reprod Genet.</a></span> 2009 Apr 22.</p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Unsal%20T%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Unsal T</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Konac%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Konac E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yesilkaya%20E%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yesilkaya E</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Yilmaz%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Yilmaz A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Bideci%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Bideci A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Ilke%20Onen%20H%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Ilke Onen H</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Cinaz%20P%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Cinaz P</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Menevse%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Menevse A</strong></a>.</div>
<p class="affiliation">Department of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Besevler, 6500, Ankara, Turkey.</p>
<p class="abstract">BACKGROUND: Polycystic ovary syndrome (PCOS), whose genetic basis is not completely well understood, is the most common endocrine disorder in women and it typically develops during adolescence. The aim of this study is to investigate the possible association between single nucleotide polymorphisms (SNPs) of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes and PCOS in adolescent girls. METHODS: DNA samples from forty-four adolescent girls with PCOS and 50 healthy controls were analyzed by PCR-RFLP and direct DNA sequencing to determine the genotypic frequency of 17 different polymorphic loci on the FSHR (A307T, N680S), CYP17 (-34 T/C), CYP1A1 (T6235C), CAPN10 (44, 43, 19, 63), INSR (exon 17 C/T), SERPINE1 (4G/5G) genes. Genotyping of exon 12 (six polymorphisms) and intron 12 (one polymorphism) of INSR gene by direct DNA sequencing was performed for the first time in this study. RESULTS: No significant differences were observed in the genotype and allele distributions of above mentioned polymorphisms between cases and control groups. CONCLUSION: Our data does not support an association between SNPs of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes and susceptibility to PCOS or related traits in Turkish adolescent girls.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/capn10/genetic-polymorphisms-of-fshr-cyp17-cyp1a1-capn10-insr-serpine1-genes-in-adolescent-girls-with-polycystic-ovary-syndrome.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Nitric oxide synthase gene polymorphisms in children with minimal change nephrotic syndrome.</title>
		<link>http://polymorphisms.info/nitric-oxide-synthase/nitric-oxide-synthase-gene-polymorphisms-in-children-with-minimal-change-nephrotic-syndrome.html</link>
		<comments>http://polymorphisms.info/nitric-oxide-synthase/nitric-oxide-synthase-gene-polymorphisms-in-children-with-minimal-change-nephrotic-syndrome.html#comments</comments>
		<pubDate>Wed, 29 Apr 2009 19:31:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Nitric oxide synthase]]></category>
		<category><![CDATA[Alasehirli]]></category>
		<category><![CDATA[CONCLUSIONS]]></category>
		<category><![CDATA[Eighty-six]]></category>
		<category><![CDATA[endothelial]]></category>
		<category><![CDATA[frequency]]></category>
		<category><![CDATA[Gaziantep]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[MATERIALS]]></category>
		<category><![CDATA[Methods]]></category>
		<category><![CDATA[neuronal]]></category>
		<category><![CDATA[Pediatr]]></category>
		<category><![CDATA[Pharmacology]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[syndrome]]></category>
		<category><![CDATA[synthase]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=224</guid>
		<description><![CDATA[Pediatr Int. 2009 Feb;51(1):75-8.

Alasehirli B, Balat A, Barlas O, Kont A.
Department of Pharmacology, Medical Faculty, Gaziantep University, Gaziantep, Turkey.
AIMS: Nitric oxide (NO) attenuates many functions within the kidney, and all NO synthase (NOS) isoforms are constitutively expressed in the kidney. But the exact role of NO in renal diseases is still debatable. The aim of [...]]]></description>
			<content:encoded><![CDATA[<h2><span title="Pediatrics international : official journal of the Japan Pediatric Society."><a href="javascript:AL_get(this, 'jour', 'Pediatr Int.');">Pediatr Int.</a></span> 2009 Feb;51(1):75-8.</h2>
<div class="authors"><!--AuthorList--></div>
<div class="authors"><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Alasehirli%20B%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Alasehirli B</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Balat%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Balat A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Barlas%20O%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Barlas O</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Kont%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Kont A</strong></a>.</div>
<p class="affiliation">Department of Pharmacology, Medical Faculty, Gaziantep University, Gaziantep, Turkey.</p>
<p class="abstract">AIMS: Nitric oxide (NO) attenuates many functions within the kidney, and all NO synthase (NOS) isoforms are constitutively expressed in the kidney. But the exact role of NO in renal diseases is still debatable. The aim of the present study was to investigate endothelial (eNOS), and neuronal (nNOS) NOS gene polymorphisms in children with minimal change nephrotic syndrome (MCNS). MATERIALS AND METHODS: Eighty-six Turkish children with clinical MCNS, ranging in age from 2 to 10 years, were compared with 114 healthy age- and sex-matched controls. The glu 298 Asp (G/T) polymorphism of the eNOS, and C276T (C/T) polymorphism of nNOS genes were genotyped using polymerase chain reaction. RESULTS: The distribution of GG, TG, and TT genotypes for eNOS was 52%, 33% and 15% in MCNS compared with 61%, 26% and 13% in the controls (P &gt; 0.05). The distribution of CC, TC, and TT genotypes for nNOS was 16%, 66% and 18% in MCNS compared with 10%, 43% and 47% in the controls. TT genotype distribution of nNOS was found to be lower in patients (P = 0.003). The eNOS and nNOS gene polymorphisms were not associated with gender, positive family history, frequency of relapses, or response to steroid. CONCLUSIONS: The present study is the first to investigate eNOS and nNOS gene polymorphisms in children with MCNS. The nNOS gene polymorphism may be associated with MCNS in children, but further studies in a larger population with different glomerular diseases are needed to confirm the results.</p>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/nitric-oxide-synthase/nitric-oxide-synthase-gene-polymorphisms-in-children-with-minimal-change-nephrotic-syndrome.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prevalence of the Angiotensin I Converting Enzyme Gene Insertion/Deletion Polymorphism in a Healthy Turkish Population.</title>
		<link>http://polymorphisms.info/cancer-kanser/kategorisiz/prevalence-of-the-angiotensin-i-converting-enzyme-gene-insertiondeletion-polymorphism-in-a-healthy-turkish-population.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/kategorisiz/prevalence-of-the-angiotensin-i-converting-enzyme-gene-insertiondeletion-polymorphism-in-a-healthy-turkish-population.html#comments</comments>
		<pubDate>Wed, 29 Apr 2009 19:29:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Kategorilenmemiş]]></category>
		<category><![CDATA[ACE]]></category>
		<category><![CDATA[Angiotensin]]></category>
		<category><![CDATA[Berdeli]]></category>
		<category><![CDATA[Biochem]]></category>
		<category><![CDATA[Caucasian]]></category>
		<category><![CDATA[Converting]]></category>
		<category><![CDATA[enzyme]]></category>
		<category><![CDATA[Faculty]]></category>
		<category><![CDATA[Gene Insertion]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Laboratory]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[prevalence]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[western Turkey]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=222</guid>
		<description><![CDATA[Biochem Genet. 2009 Apr 24.

Berdeli A, Cam FS.
Molecular Medicine Laboratory, Department of Pediatrics, Faculty of Medicine, Ege University, Izmir, Turkey.
Angiotensin converting enzyme (ACE) plays an essential role in the renin-angiotensin system. It converts angiotensin I to angiotensin II and inactivates bradykinin and tachykinins. Numerous studies have been published investigating associations of the ACE gene I/D [...]]]></description>
			<content:encoded><![CDATA[<p><span title="Biochemical genetics."><a href="javascript:AL_get(this, 'jour', 'Biochem Genet.');">Biochem Genet.</a></span> 2009 Apr 24.</p>
<dd class="abstract">
<div class="authors"><!--AuthorList--><a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Berdeli%20A%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Berdeli A</strong></a>, <a href="http://polymorphisms.info/sites/entrez?Db=pubmed&amp;Cmd=Search&amp;Term=%22Cam%20FS%22%5BAuthor%5D&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus"><strong>Cam FS</strong></a>.</div>
<p class="affiliation">Molecular Medicine Laboratory, Department of Pediatrics, Faculty of Medicine, Ege University, Izmir, Turkey.</p>
<p class="abstract">Angiotensin converting enzyme (ACE) plays an essential role in the renin-angiotensin system. It converts angiotensin I to angiotensin II and inactivates bradykinin and tachykinins. Numerous studies have been published investigating associations of the ACE gene I/D polymorphism with various pathophysiological conditions. We examined the prevalence of the ACE I/D polymorphism in a sample of healthy volunteers from western Turkey, including 1063 healthy Turkish controls. Analysis of the ACE I/D gene polymorphisms by polymerase chain reaction found frequencies of 16.1% for the II genotype, 47.7% for the ID genotype, and 36.2% for the DD genotype. The allele frequency was 39.9% for the I alleles and 60.1% for the D allele. This study demonstrates that the allele and genotype frequency values for the Turkish population are similar to previously published frequencies for Caucasian populations.</p>
</dd>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/kategorisiz/prevalence-of-the-angiotensin-i-converting-enzyme-gene-insertiondeletion-polymorphism-in-a-healthy-turkish-population.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

